(11aS,11a'S)-8,8'-(Pentane-1,5-diylbis(oxy))bis(7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one)

Catalog No. :
ACKZKJ922
CAS No. :
145325-57-1
Molecular Formula :
C31H36N4O6
Molecular Weight :
560.65

IUPAC Name:(11aS,11a'S)-8,8'-(pentane-1,5-diylbis(oxy))bis(7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one)

(11aS,11a'S)-8,8'-(Pentane-1,5-diylbis(oxy))bis(7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$408.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(11aS,11a'S)-8,8'-(Pentane-1,5-diylbis(oxy))bis(7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one)
IUPAC Name(11aS,11a'S)-8,8'-(pentane-1,5-diylbis(oxy))bis(7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one)
Molecular FormulaC31H36N4O6
Molecular Weight560.65
SMILESO=C1C2=CC(OC)=C(OCCCCCOC3=C(OC)C=C4C(N=C[C@@](CCC5)([H])N5C4=O)=C3)C=C2N=C[C@@]6([H])N1CCC6
InChI KeyJMRUKTNVBSHJFI-SFTDATJTSA-N
Synonym5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one, 8,8'-[1,5-pentanediylbis(oxy)]bis[1,2,3,11a-tetrahydro-7-methoxy-, (11aS,11'aS)-;PBD dimer-2
CAS No.145325-57-1

Synthetic Route by SureRoute

1. ACKZKJ922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKZKJ922 route product structure diagram
    ACKZKJ922145325-57-1
Inquiry

2. ACKZKJ922 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKZKJ922 route product structure diagram
    ACKZKJ922145325-57-1
Inquiry

Comments (0)